October 17, 2019 – New York, US – As the core section of the innate immunity which improves the lethal effect of antibodies and phagocytic cells during the defense against microbes, apoptotic and necrotic cells from an organism, the complement system is probably capable to connect innate and adaptive immune response. Focusing on this crucial factor, Creative Biolabs has launched a series of solutions, covering the complement system complex development, complement therapeutic services and complement associated products.
Targeting at the classical pathway of complement system, which is initiated by C-reactive protein, viral proteins, polyanions, apoptotic cells, and amyloid, there are comprehensive therapeutic antibodies, inhibitors, soluble complement regulators provided, including C1 Complex, C1 Inhibitor, C2 complement, C3 complement, and so on, developed under the support of the advanced technology platform.
Aside from the classical, lectin and alternative pathways, another crucial activation of the complement system is Membrane Attack Complex (MAC), with other names as terminal complement complex (TCC), formed up by C5b together with additional components like C7, C9 and C6 complement.
First-level services regarding the complement therapeutics are provided under the joint efforts from Creative Biolabs’ scientific staff, who have designed the outstanding platform on which to conduct clients’ projects of five types.
1. Complement test services
2. Therapeutic antibody development
3. Soluble complement regulator development (including complement inhibitor)
4. Serine protease inhibitor development
5. Complement component inhibitor development
6. Anaphylatoxin receptor antagonist development
The project process can be designed to meet every unique requirement to support clients’ complement-based drug discovery, with the following highlights:
• Extensive experience and advanced biotechnologies
• Fully customizable experimental design to meet customers’ needs
• Competitive price with the best quality
• Best after-sale service
Sufficient dock of products regarding the complement therapeutics are provided, applicable to a variety of diseases like lupus recurrent infection, erythematosus (SLE), rheumatic diseases, cancer, Alzheimer’s disease, and etcetera. Product catalog includes antibodies, proteins, inhibitors, peptides and assay kits, which are of high quality and can be applied for proving, target validation, and working as positive controls.
For years, Creative Biolabs never stops the step to progress, from advanced lab technologies to the customer-first service concept. Therefore, the services, products and other packages are ensured for the outcomes of high standards concerning the complement therapeutics. If more relevant message is needed, please visit https://www.creative-biolabs.com/complement-therapeutics/.
About the Company
Creative Biolabs is a US-based leading global biologics company with more than 10 years’ exploration and expansion in the biotech/pharmaceutical market, which has expanded the research and service capacity to the full pipeline of drug discovery and development industries.
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States